Planned first safety and efficacy analysis of oral fludarabine combined with subcutaneous alemtuzumab in 2(nd) line therapy of B-chronic lymphocytic leukaemia (B-CLL): The FLUSALEM study.

Egle, A; Tinhofer, I; Russ, G; Rass, C; Greil, R BLOOD. 2006; 108(11): 336B-336B.

Wie sterben wir? Wie schön ist der Tod? Wie teuer ist der Tod? – Die Palliativmedizin im Spannungsfeld der Ressourcenallokation

Greil, R; In: Fischer, M; Zänker, KS; editors(s). Medizin- und Bioethik. (ISBN: 978-3-631-54744-1 )

Lymphoproliferative Erkrankungen.

Greil, R; 2006.

The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year results of ABCSG-05 (CMF vs. goserelin plus tamoxifen).

Gnant, M; Greil, R; Kubista, E; Menzel, C; Schippinger, W; Seifert, M; Haider, K; Mlineritsch, B; Samonigg, H; Kwasny, W; Fridrik, M; Steger, G; Steindorfer, P; Schmelitsch, J; Poetter, R; Jakesz, R; BREAST CANCER RESEARCH AND TREATMENT_x000D_ . 2006. 100: 10-11.

A role of TRAIL in killing osteoblasts by myeloma cells

Tinhofer, I; Biedermann, R; Krismer, M; Crazzolara, R; Greil, R FASEB J. 2006; 20(1): 759-+.

The still long and winding road to neoadjuvant sytemic therapy as the standard of care in breast cancer

Greil, R BREAST CARE. 2006; 1(6): 352-357.

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Falkensammer, C; Jöhrer, K; Gander, H; Ramoner, R; Putz, T; Rahm, A; Greil, R; Bartsch, G; Thurnher, M; Cancer Immunol Immunother. 2006; 55(10): 1228-1237.

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

Steurer, M; Pall, G; Richards, S; Schwarzer, G; Bohlius, J; Greil, R; CANCER TREAT REV. 2006; 32(5): 377-389.

Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study.

Marth, C; Windbichler, GH; Hausmaninger, H; Petru, E; Estermann, K; Pelzer, A; Mueller-Holzner, E; INT J GYNECOL CANCER. 2006; 16(4): 1522-1528.

Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature.

Mian, M; Rass, C; Hutarew, G; Kofler, B; Fiegl, M; Greil, R; LEUKEMIA LYMPHOMA. 2006; 47(8): 1683-1685.